H Maeda

Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD.

H. Maeda, F. Suzuki, T. Akaike, 1989, Science.

[General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics].

H. Maeda, Y. Matsumura, T Oda, 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

Tumoritropic and lymphotropic principles of macromolecular drugs.

H. Maeda, Y. Matsumura, H Maeda, 1989, Critical reviews in therapeutic drug carrier systems.

Bradykinin and nitric oxide in infectious disease and cancer.

H. Maeda, T. Akaike, J. Wu, 1996, Immunopharmacology.

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

H. Maeda, H Maeda, G Y Bharate, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

H. Maeda, T. Sawa, H Maeda, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.

H. Maeda, T. Akaike, S. Sahoo, 2002, Bioconjugate chemistry.

Nitric oxide and oxygen radicals in infection, inflammation, and cancer.

H. Maeda, T. Akaike, T Akaike, 1998, Biochemistry. Biokhimiia.

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.

H. Maeda, H Maeda, H. Maeda, 1991, Advanced drug delivery reviews.

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

H. Maeda, Y. Matsumura, H Maeda, 1986, Cancer research.